BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11796505)

  • 1. Early stimulation and late inhibition of extracellular signal-regulated kinase 1/2 phosphorylation by IGF-I: a potential mechanism mediating the switch in IGF-I action on skeletal muscle cell differentiation.
    Adi S; Bin-Abbas B; Wu NY; Rosenthal SM
    Endocrinology; 2002 Feb; 143(2):511-6. PubMed ID: 11796505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Akt phosphorylation is not sufficient for insulin-like growth factor-stimulated myogenin expression but must be accompanied by down-regulation of mitogen-activated protein kinase/extracellular signal-regulated kinase phosphorylation.
    Tiffin N; Adi S; Stokoe D; Wu NY; Rosenthal SM
    Endocrinology; 2004 Nov; 145(11):4991-6. PubMed ID: 15489316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of insulin-like growth factor actions in L6A1 myoblasts by insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5: a dual role for IGFBP-5.
    Ewton DZ; Coolican SA; Mohan S; Chernausek SD; Florini JR
    J Cell Physiol; 1998 Oct; 177(1):47-57. PubMed ID: 9731744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells.
    Halevy O; Cantley LC
    Exp Cell Res; 2004 Jul; 297(1):224-34. PubMed ID: 15194438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposing early inhibitory and late stimulatory effects of insulin-like growth factor-I on myogenin gene transcription.
    Adi S; Cheng ZQ; Zhang PL; Wu NY; Mellon SH; Rosenthal SM
    J Cell Biochem; 2000 Jun; 78(4):617-26. PubMed ID: 10861859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposing early and late effects of insulin-like growth factor I on differentiation and the cell cycle regulatory retinoblastoma protein in skeletal myoblasts.
    Rosenthal SM; Cheng ZQ
    Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10307-11. PubMed ID: 7479773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor (IGF)-binding protein-related protein-1: an autocrine/paracrine factor that inhibits skeletal myoblast differentiation but permits proliferation in response to IGF.
    Haugk KL; Wilson HM; Swisshelm K; Quinn LS
    Endocrinology; 2000 Jan; 141(1):100-10. PubMed ID: 10614628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular signal-regulated kinase-1 and -2 respond differently to mitogenic and differentiative signaling pathways in myoblasts.
    Sarbassov DD; Jones LG; Peterson CA
    Mol Endocrinol; 1997 Dec; 11(13):2038-47. PubMed ID: 9415407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERK1/2 is required for myoblast proliferation but is dispensable for muscle gene expression and cell fusion.
    Jones NC; Fedorov YV; Rosenthal RS; Olwin BB
    J Cell Physiol; 2001 Jan; 186(1):104-15. PubMed ID: 11147804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raf-1 activation stimulates proliferation and inhibits IGF-stimulated differentiation in L6A1 myoblasts.
    Samuel DS; Ewton DZ; Coolican SA; Petley TD; McWade FJ; Florini JR
    Horm Metab Res; 1999; 31(2-3):55-64. PubMed ID: 10226782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of scaffolding adaptor protein Gab1 with tyrosine phosphatase SHP2 negatively regulates IGF-I-dependent myogenic differentiation via the ERK1/2 signaling pathway.
    Koyama T; Nakaoka Y; Fujio Y; Hirota H; Nishida K; Sugiyama S; Okamoto K; Yamauchi-Takihara K; Yoshimura M; Mochizuki S; Hori M; Hirano T; Mochizuki N
    J Biol Chem; 2008 Aug; 283(35):24234-44. PubMed ID: 18577518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor-alpha and basic fibroblast growth factor differentially inhibit the insulin-like growth factor-I induced expression of myogenin in C2C12 myoblasts.
    Layne MD; Farmer SR
    Exp Cell Res; 1999 May; 249(1):177-87. PubMed ID: 10328964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical proliferation-independent window for basic fibroblast growth factor repression of myogenesis via the p42/p44 MAPK signaling pathway.
    Tortorella LL; Milasincic DJ; Pilch PF
    J Biol Chem; 2001 Apr; 276(17):13709-17. PubMed ID: 11279003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of insulin-like growth factor II (IGF-II), IGF binding protein-2 and myogenin during differentiation of myogenic satellite cells derived from the turkey.
    Ernst CW; McFarland DC; White ME
    Differentiation; 1996 Oct; 61(1):25-33. PubMed ID: 8921582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluvastatin attenuates IGF-1-induced ERK1/2 activation and cell proliferation by mevalonic acid depletion in human mesangial cells.
    Shibata T; Tamura M; Kabashima N; Serino R; Tokunaga M; Matsumoto M; Miyamoto T; Miyazaki M; Furuno Y; Takeuchi M; Abe H; Okazaki M; Otsuji Y
    Life Sci; 2009 May; 84(21-22):725-31. PubMed ID: 19254730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-jun N-terminal kinase mediates tumor necrosis factor-alpha suppression of differentiation in myoblasts.
    Strle K; Broussard SR; McCusker RH; Shen WH; LeCleir JM; Johnson RW; Freund GG; Dantzer R; Kelley KW
    Endocrinology; 2006 Sep; 147(9):4363-73. PubMed ID: 16777978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erk1-Erk2 and phosphatidylinositol 3'-kinase-Akt signaling pathways.
    Thimmaiah KN; Easton J; Huang S; Veverka KA; Germain GS; Harwood FC; Houghton PJ
    Cancer Res; 2003 Jan; 63(2):364-74. PubMed ID: 12543789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adiponectin inhibits insulin-like growth factor-1-induced cell migration by the suppression of extracellular signal-regulated kinase 1/2 activation, but not Akt in vascular smooth muscle cells.
    Motobayashi Y; Izawa-Ishizawa Y; Ishizawa K; Orino S; Yamaguchi K; Kawazoe K; Hamano S; Tsuchiya K; Tomita S; Tamaki T
    Hypertens Res; 2009 Mar; 32(3):188-93. PubMed ID: 19262481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-Myc induction stimulated by insulin-like growth factor I through mitogen-activated protein kinase signaling pathway in human neuroblastoma cells.
    Misawa A; Hosoi H; Arimoto A; Shikata T; Akioka S; Matsumura T; Houghton PJ; Sawada T
    Cancer Res; 2000 Jan; 60(1):64-9. PubMed ID: 10646854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor-I-coupled mitogenic signaling in primary cultured human skeletal muscle cells and in C2C12 myoblasts. A central role of protein kinase Cdelta.
    Czifra G; Tóth IB; Marincsák R; Juhász I; Kovács I; Acs P; Kovács L; Blumberg PM; Bíró T
    Cell Signal; 2006 Sep; 18(9):1461-72. PubMed ID: 16403461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.